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Abstract
Background: Bacterial infections are a significant cause of sickness and death in sub-Saharan Africa. This study
aimed at establishing the prevalence, distribution and antimicrobial susceptibility pattern of major bacterial isolates
from patients accessing medical care at a tertiary hospital in Malawi.
Methods: We retrospectively reviewed bacteria culture and antimicrobial susceptibility records for 4617 patients
from 2002 to 2014 at Mzuzu Central Hospital (MCH). No inclusion and exclusion criteria were followed. Data was
analysed using excel (Microsoft office, USA) and GraphPad prism 7 software programs.
Results: The most prevalent isolates were S. aureus (34.7%, n = 783), Klebsiella species (17.4%, n = 393) and Proteus
species (11.4%, n = 256). Most microorganisms were isolated from adults (88.3%, n = 3889) and pus was the main
source (69.3%, n = 1224). S. pneumoniae was predominantly isolated from cerebrospinal fluid (60.3%, n = 44) largely
collected from children (88.2%, n = 64). Overall, most bacteria exhibited high resistance to all regularly used
antimicrobials excluding ciprofloxacin.
Conclusions: Our report demonstrates an increase in bacterial infection burden in sites other than blood stream
and subsequent increase in prevalence of antimicrobial resistance for all major isolates. Creating an epidemiological
survey unit at MCH will be essential to help inform better treatment and management options for patients with
bacterial infections.
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Background
Bacterial diseases remain the major cause of morbidity
and mortality worldwide [1]. Infectious diseases are pre-
dominant in Africa and are largely influenced by vulner-
able population, social inequality and poor health
delivery systems [1]. Inadequate funding, poor micro-
biology services, limited technical experts and scarce
epidemiological data to inform better preventive and
treatment strategies all contribute to the rise in burden
of bacterial infections in Africa [2, 3]. This increase in
the burden of bacterial infections is also accompanied by
high incidences of antimicrobial resistance (AMR) [4].
As a low income country in Africa, Malawi is no excep-
tion to these challenges [5].
Across Africa, AMR has been reported in different
countries. Apart from the emergence of Methicillin-
resistant Staphylococcus aureus (MRSA), Malawi has re-
ported a rapid increase in non-Salmonella Enterobacteri-
aceae with extended spectrum beta-lactamase (ESBL)
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and fluoroquinolone resistance among common Gram-
negative pathogens [5]. In Zimbabwe, Gram-negative
bacteria showed high resistance to cotrimoxazole
(68.5%) and ampicillin (84.5%) while Gram-positive bac-
teria demonstrated resistance to cotrimoxazole (69%)
and Nalidixic acid (81%) [6]. A study in Ghana revealed
that Neisseria gonorrhoeae isolates were resistant to
tetracycline (100%), benzylpenicillin (90.9%) and cipro-
floxacin (88.6%) [7]. In general, important Gram-
negative bacteria including Klesbsiella, E. coli, Salmon-
ella, Shigella and Gram-positive bacteria such as S.
pneumoniae, S. aureus, S. agalactae, (MRSA) across Af-
rica have acquired resistance to the common essential
antimicrobials being used in the region [8].
The rise in AMR has been attributed to several factors
such as bad clinical practices, poor public perception
and behaviour towards antimicrobial use, increase in ad-
verse agricultural practices etc. [9]. Most importantly, ir-
responsible widespread use of antimicrobials creates a
sturdy selective pressure that propels the adaptive and
evolutionary response by microbes, hence the emergence
of various AMR phenotypes [9]. Worse still, today’s glo-
bal economy allows people to travel and interact world-
wide which enables transmission and spread of
pathogens worldwide [9]. The rise in AMR not only
threatens the public health sector but also the already
fragile economies in the African continent through pro-
longed hospitalization and use of expensive and specia-
lised treatment and care for the sick.
It is generally accepted that AMR is a global threat
mostly affecting low-income countries, however most
data available on bacterial pathogen surveillance and
AMR profile is from high-income countries [8]. Never-
theless, in Africa, many countries use syndromic ap-
proaches to treat bacterial infections. In order to be
effective, empirical treatment requires better knowledge
of local AMR profiles. The aim of this study was to de-
termine the prevalence, distribution and antimicrobial
susceptibility patterns of commonly isolated pathogenic
bacteria at Mzuzu Central Hospital (MCH), a referral




We conducted a retrospective audit of records for bac-
terial culture and susceptibility testing results between
the years 2002 and 2014 from MCH microbiology la-
boratory department. No inclusion and exclusion criteria
were applied. The MCH Laboratory participates in inter-
national microbiology quality assessment programs such
as the UK External Quality Assessment program
(UKNEQAS) and Zimbabwe Quality Assurance Program
(ZIMQAP). Ethical approval for the study was obtained
from National Health Science Research Committee
(NHSRC; approval number NHSRC # 1206).
Bacterial identification and characterisation
Specimens from outpatient department and clinical
wards were transported to microbiology department la-
boratory for analysis within 2 h of collection. Conven-
tional microbiological culture methods were employed
to isolate and identify bacteria. Media was prepared in-
house as per procedures stipulated in Cheesbrough [10].
About 10 mL and 3mL of blood collected from adults
and paediatric patients, respectively were inoculated into
BD Bactec plus aerobic culture vials™ for incubation at
35–37 °C in BD Bactec™ 9050 Blood Culture System
(BD, USA). Positive cultures were sub-cultured onto
Blood Agar Plate (BAP), MacConkey Agar Plate (MAP)
or Chocolate Agar Plate (CAP) if any fastidious organ-
ism was suspected. Inoculated plates were incubated at
37 °C, 5% CO2 for up to 72 h.
Swabs collected from wounds, skin and soft tissue in-
fection were Gram stained, cultured on either BAP/CAP
or MAP, and, incubated at 37 °C,5% CO2 for up to 72 h
[10]. Swabs collected from cerebrospinal fluid (CSF) and
other fluids, were Gram stained, cultured on BAP and
CAP for incubation at 37 °C,5% CO2 for up to 72 h [10].
Urine samples were inoculated on CLED agar and incu-
bated at 37 °C for up to 48 h [10]. A specimen was con-
sidered positive for urinary tract infection (UTI) if the
number of enumerated colonies were greater than ≥105
CFU/mL [10, 11].
Isolates were identified and processed according to
standard techniques summarised in Table 1. Antibiotic
susceptibility was determined by disc diffusion technique
on Mueller -Hinton agar except for Streptococcus pneu-
monia and other fastidious organisms, the Mueller-
Hinton agar was supplemented with 5% human blood
(from blood donors). Data was interpreted according to
the CLSI guidelines with quality-controlled strains; Escher-
ichia coli ATCC 25922 and Staphylococcus aureus ATCC
25923 [12]. Major bacterial isolates were evaluated for
their susceptibility against the most commonly used anti-
microbials during the study period. Antimicrobial screen-
ing was performed with the following antibiotics:
ciprofloxacin, ceftriaxone, penicillin, tetracycline, ampicil-
lin, chloramphenicol, amoxicillin, and gentamicin.
Data analysis
Data was analysed using Excel (Microsoft office, USA)
and GraphPad Prism 7 software (San Diego, CA,
USA). Graphs or pie chart were used to show the
prevalence and distribution of the isolated bacteria
against gender (male and female), age groups (Chil-
dren and adults) and specimens (Pus, ear swab, V.
Blood, Cerebral Spinal Fluids, High Vaginal Swabs,
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Urine and Other fluids). In addition, a frequency table
expressed in percentage and absolute numbers was
used to display the susceptibility patterns of the six
commonly isolated bacteria against the six commonly
used antibiotics.
Results
Study population and demographics
To understand the demographics of the patient popu-
lation, clients were characterised according to their
sex and age group. Out of 4617 patients who
Table 1 Laboratory methods for bacteria identification and susceptibility testing
Organism Media Tests for presumptive identification Susceptibility testing Method


















































Fig. 1 Demographics of the study population. Patients were categorised by gender and age group
Kumwenda et al. BMC Infectious Diseases           (2021) 21:34 Page 3 of 10
Fig. 2 Distribution of isolates by specimen source and hospital department. Absolute number of (a) specimens and (b) isolates recovered per
department were determined
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submitted samples for microbial analysis, 2246 (49%)
were male and 2371 (51%) were female (Fig. 1). We
observed that 84% (n =3889) were adult patients (>
12 years old) while were 11% (n =517) were children
(≤12 years old) (Fig. 1).
Analysis of isolates by source of specimen and hospital
department
To analyse the dynamics of bacterial infections, total
number of specimens collected and isolates recovered
were determined for each hospital department. Most
samples were collected in the Out Patient Department
(OPD;1885, 43%; Fig. 2a). Pus from wound and ear in-
fections were the most frequent samples and the major-
ity of them were collected in the OPD, male surgical
ward, paediatric ward and female surgical ward (Fig. 2a).
Corresponding to the high number of samples collected,
the OPD had the highest number of bacterial isolates
(784, 44.5%; Fig. 2a). TB ward had the least number of
isolates (20, 1.1%). Across the departments, S. aureus
was the most isolated pathogen (783, 43.5%) followed by
Klebsiella species (387, 22%) (Fig. 2b).
Prevalence of bacterial isolates
To evaluate the prevalence of bacteria pathogens over
the study period, we determined the overall numbers of
individual isolates and established the comprehensive
figure of pathogens per year. Staphylococcus aureus was
the most commonly isolated bacterium (783, 34.7%)
(Fig. 3a). Other common isolates included Klebsiella
species (393, 17.4%), Proteus species (256, 11.4%), Co-
agulase-Negative Staphylococcus (193, 8.6%), Escherichia
coli (169, 7.5%) and Pseudomonas species (131, 5.8%; Fig.
3a). The pattern of number of patients over the years
matched the pattern of positive cultures. As the num-
ber of patients increased or decreased so did the
number of positive cultures (Fig. 3b). Altogether, the
culture positivity rate was approximately 48.9% (2258/
4611). Assuming that each patient submitted one
sample, the highest culture positivity rate was
Fig. 3 Prevalence of bacterial pathogens over the 13-year period. a Shows the prevalence of isolates during the study period. b Describes the
distribution of patients alongside positive cultures throughout the study period. c Demonstrate the culture positivity rates in different years of the
investigation period
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recorded in 2011 (212/367; 57.7%) whereas the lowest
rate was registered in 2005 (85/284; 29.9%; Fig. 3c).
In 2011, 54.2% (115/212) of the bacteria isolates were
gram negative with Klebsiella species being dominant
(25/115; 21.7%).
Distribution of bacterial isolates according to
demographics
To identify the most susceptible group from bacterial in-
fections, isolates were distributed according to gender
and age groups of the patients. The percentage of male
Fig. 4 Prevalence of bacterial isolates per gender and age group. Isolated bacteria were distributed according to sex (a) and age group (b) of
the patients
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and female patients whose samples were positive for
bacterial culture was roughly the same i.e. 51 and 49%
respectively (Fig. 4a). A significant number of bacterial
isolates were isolated from patients aged more than 12
years (Fig. 4b). Largely, the distribution of isolates
among male and females was fairly similar with preva-
lence rates of within 50% except for Pseudomonas spe-
cies which were isolated more in males than females
(63.1, 36.9% respectively; Fig. 4a). Most of the isolates
were recovered from patients older than 12 years except
S. pneumoniae which was isolated predominantly in cli-
ents younger than 12 years (88.2%; Fig. 4b).
Antimicrobial susceptibility profiles of major bacterial
isolates
To assess antimicrobial susceptibility, most commonly
isolated bacteria were tested for their susceptibility to
the most commonly used antimicrobials at the hospital
during the 13-year period. In comparison to other path-
ogens, S. pneumoniae demonstrated the highest rate of
susceptibility to most of the antibiotics except for genta-
micin where 40% of the strains showed resistance
(Table 2). In this study, ciprofloxacin followed by genta-
micin and cotrimoxazole proved to be the most effective
antimicrobials with overall pathogen susceptibility rates
of 84, 75 and 70% respectively (Table 2). Nonetheless,
worrying levels of antimicrobial resistance was registered
in the study. On the whole, Pseudomonas species exhib-
ited relatively the highest resistance to most antibiotics.
Overall, high rates of antimicrobial resistance to
erythromycin (49%), chloramphenicol (47%), and nali-
dixic acid (42%) were recorded (Table 1).
Discussion
Understanding distribution of microbial pathogens and
their associated infections is essential for controlling in-
fectious diseases and monitoring of antimicrobial resist-
ance. The current study aimed at establishing the
prevalence of common pathogenic bacteria including
their antimicrobial susceptibility patterns and distribu-
tion according to specimens, age groups and sex at
Mzuzu Central hospital. We report a high prevalence of
bacteria isolates with variability in susceptibility to key
antimicrobials used during the study period. Most iso-
lates displayed high resistance to erythromycin, gentami-
cin, chloramphenicol, nalidixic acid and cotrimoxazole.
Conversely, majority of the isolates were sensitive to
ciprofloxacin.
While a significant number of similar studies in
Malawi were limited to investigating blood stream bac-
terial infections [5, 13–18], our study demonstrated the
spread of bacterial infections where other body sites
were surveyed (Fig. 2a-b). The high prevalence of bac-
teria isolates observed in this study (Fig. 3a) highlights
the need for effective monitoring and surveillance of
bacterial infections in resource-limited health care set-
tings. There was a sharp decrease in number of isolates
tested between 2003 and 2006 (Fig. 3b), followed by a slow
appreciation in subsequent years. Among other reasons,
we suggest that this might have been as a result of reduced
Table 2 Antimicrobial susceptibility patterns of major bacterial pathogens against commonly used antimicrobials during 2002–2014
period. The numbers in the table represent isolates found to be susceptible and resistant to the antimicrobials
Key: NA Not Applicable, S Susceptible, R Resistance
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capacity of the laboratory to perform microbiology testing
services. In 2004, the Malawi government had parted ways
with a major donor supporting services at Mzuzu Central
Hospital. Several services including laboratory services
were negatively affected until a few years later when the
government devised ways to fill the gap.
Similar to previous investigations [19–24], our findings
revealed that S. aureus was the predominant cause of
bacterial infections (Fig. 3a). S. aureus is the common
cause of skin and soft tissue infections [25, 26]. Hence it
is not surprising that we observed considerably high
number of isolates from OPD, male surgical ward and
female surgical ward following culture of pus obtained
from wound and surgical site infections. The subsequent
prevalent pathogens in the study were Klebsiella and
Proteus species (Fig. 3a), which were also mostly recov-
ered from wound pus. Likewise, this observation is com-
parable to investigations conducted in other countries
[22, 23, 26–28].
The fluctuations in the number of patients that were
provided with microbiology services correspond with the
number of positive cultures. As the number of patients
increased, positive cultures also increased and vice versa
(Fig. 3b). The relatively high bacterial culture positivity
rates observed (Fig. 3c) in this study could suggest good
culture and bacterial isolation techniques. On the other
hand, this could also be as a result of more contami-
nants being isolated, as most of the isolates i.e. S. aureus
were isolated from pus, which can easily be contami-
nated with skin flora.
Except for S. pneumoniae most of the pathogens were
isolated from patients > 12 years old and adult patients
(Fig. 4b). The study registered more adults than children
hence the observation that more isolates were recovered
from adults corresponds with the high number of adult
clients registered. S. pneumoniae is a common cause of
bacterial meningitis in children [29], as such, our finding
is consistent with literature. Correspondingly, our study
showed that S. pneumoniae was predominantly isolated
from CSF largely collected from children.
In general, all major isolates showed relatively high re-
sistance to essential antimicrobials used during the study
period (Table 2). Similar to previous studies [19, 30], our
investigation showed higher rates of S. aureus resistance
to chloramphenicol and erythromycin. Methicillin-
resistant Staphylococcus aureus (MRSA) has significantly
contributed to antimicrobial resistance globally [31],
hence the drawback in this investigation is that S. aureus
isolates were not tested to determine if some of the iso-
lates were of MRSA origin.
S. pneumonia is a significant cause of pneumonia, sep-
sis, bacterial meningitis and death in Malawian children
and adults [32–35]. Chloramphenicol is one of the antibi-
otics used in the treatment of bacterial meningitis
including invasive pneumococcal diseases in Malawi. Pre-
vious investigations in Malawi reported higher rates of S.
pneumoniae resistance to chloramphenicol which is in
contrast to the findings in our study [5, 19]. Our observa-
tion needs to be interpreted with care since the number of
isolates analysed in the current study is smaller than previ-
ous studies, hence, comparing the rates of antimicrobials
resistance may not give a true reflection of the real situ-
ation. However, in general all major isolates exhibited high
resistance to chloramphenicol.
The high rates of resistance to chloramphenicol, cotri-
moxazole and nalidixic acid by major gram-negative or-
ganisms in the study is of concern as we observed a
large population of patients affected during the study
period. This is of importance as studies have shown an
increased risk of subsequent infection and mortality after
hospital discharge following colonisation with drug re-
sistant gram-negative bacteria [36]. Whilst drug resistant
Gram-negative bacteria are recognised as a global prob-
lem in resource limited countries, the threat is much
higher in areas with poor healthcare infrastructure and
poor surveillance for antimicrobial resistance.
According to the Malawi Standard Treatment Guide-
lines, the antimicrobials used in the study are essential
in the treatment of several conditions including sepsis,
chronic diarrhoea and infant bacillary dysentery respect-
ively [37]. In addition, cotrimoxazole is used as a
prophylactic treatment for bacterial infections in HIV
positive clients in the WHO clinical stages II, III and IV
[37]. Overall, it is encouraging that ciprofloxacin proved
to be relatively effective against most pathogens. In
Malawi, ciprofloxacin is used in the treatment of bacil-
lary dysentery in adults, sepsis, and also as a prophylactic
treatment for meningococcal meningitis in adults [37].
Limitations
Some of the limitations of this study include lack of pa-
tient history on previous antimicrobial use. Conse-
quently, this might have an influence on the observed
rate of antimicrobial resistance. Secondly, due to limited
availability of raw data, we were not able to capture an
in-depth analysis of critical epidemiological data such as
name of referral hospitals for the patients, onset of dis-
ease, occupation, and HIV status. The study was con-
ducted at one tertiary hospital in northern Malawi as
such the findings cannot be generalized to the whole
country. Lastly, laboratory data on pathogen isolation,
identification and susceptibility testing was generated
using conventional methods, hence the results may be
limited. Nevertheless, this study has provided an aware-
ness on common microorganism isolated in our set up,
their distributions and antimicrobial resistance pattern.
This data could help practitioners and policy makers to
make informed decisions on management of patients.
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Conclusions
As a result of several social and public health interven-
tions, Malawi has over the years recorded a marked de-
cline in the incidence of bacterial bloodstream infections
[5]. However, this study has demonstrated an increase in
bacteria burden in sites other than blood stream as well
as a concurrent increase in prevalence of antimicrobial
resistance. The increased rates of antimicrobial resist-
ance revealed in the study could be due to poor clinical
practices or irrational use of antibiotics by the public.
Nevertheless, to fight against antimicrobial resistance, a
local epidemiological surveillance program is needed to
guide in the generation of evidence-based guidelines for
the treatment and management of bacterial infections.
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